Showing results (1861-1870 of 2,587) with videos related to

Sort By:
Pageof 259
Molecular Oncology|August 14, 2025
EGFR-STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1-positive prostate cancerElsa Gomes Paiva, Bernardo Orr, Ana Azeredo, et al.
Molecular Oncology|February 9, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasisNorbert Wronski, Sławomir Lasota, Ewelina Madej, et al.
Molecular Oncology|February 13, 2026
Engineered extracellular vesicles enriched with the miR-214/199a cluster enhance the efficacy of chemotherapy in ovarian cancerWeida Wang, Ayesha Alvero, Yi Qin, et al.
Molecular Oncology|February 9, 2026
TRAIL-PEG-Apt-PLGA nanosystem as an aptamer-targeted drug delivery system potential for triple-negative breast cancer therapy using in vivo mouse modelGulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, et al.
Molecular Oncology|November 16, 2022
KRAS inhibitors: going noncovalentMatthias Drosten, Mariano Barbacid
Molecular Oncology|February 3, 2026
Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancerMartina Poturnajova, Zuzana Kozovska, Ondrej Pos, et al.
Molecular Oncology|January 27, 2026
Tumor mutational burden as a determinant of metastatic dissemination patternsEduardo Candeal, Andrea Moreno-Manuel, Miguel Salvadó-Pertierra, et al.
Molecular Oncology|February 3, 2026
Targeted modulation of IGFL2-AS1 reveals its translational potential in cervical adenocarcinomaRicardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, et al.
Molecular Oncology|June 8, 2025
The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl-xL or Mcl-1 in ovarian cancerCécilia Thomine, Sterenn Guillemot, Louis-Bastien Weiswald, et al.
Molecular Oncology|June 10, 2025
Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease modelsJohanna Classon, Moa Stenudd, Margherita Zamboni, et al.
Pageof 259